Introduction Welcome to Pharmaprojects’ 2021 review of trends in pharmaceutical R&D. For almost 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article I’ll examine the state of play at the start of 2021.
Improve your clinical trial decisions and cycle times
Have you ever had a clinical trial impacted by under-performing clinical trial sites? Have you ever had to quickly mitigate risk when the time, cost, or resource required for study start-up differs from expectations?
What if you could accurately identify quality sites based on a combination of factors and understand the impact of selected sites on predicted enrollment timelines and durations?
Introducing Citeline Study Feasibility
Be one of the first to benefit from industry-leading technology that will help you:
About Citeline Study Feasibility
Citeline Study Feasibility is a platform that combines subject matter expertise and machine-learning to develop predictive insights for feasibility planning. We are accelerating clinical trial timelines by bringing together our technical/machine-learning capabilities with our expertly curated, best-in-class clinical data sets, which are built on standardized ontologies and enriched by domain knowledge and natural language processing (NLP).
In a single platform, these predictive insights can be modeled and optimized with explain-ability and transparency:
Why Citeline Study Feasibility?
There are 4 major expected business benefits for clients who use Citeline Study Feasibility:
Our data science approach combines advanced machine-learning with gold-standard data, resulting in a powerful solution that is far superior to traditional approaches for clinical trial feasibility
Register your interest today to be one of the first to benefit from Citeline Study Feasibility
In 2017, Informa Pharma Intelligence took a deep dive into the clinical trial landscape in China over the previous 10 years, in a whitepaper entitled “Is China the Dark Horse in Clinical Development?”. That analysis showed that the number of trial starts in China had been trending upwards year-on-year and suggested that China was on course to become a formidable player within the pharma industry on a global stage.
Topics Clinical Trials
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: